28.01.2015 Views

2007 1. Adamek, A., et al., High dose aspirin and left ventricular ...

2007 1. Adamek, A., et al., High dose aspirin and left ventricular ...

2007 1. Adamek, A., et al., High dose aspirin and left ventricular ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

function<strong>al</strong> b<strong>et</strong>a1-adrenergic receptor autoantibodies in heart failure. J Am Coll<br />

Cardiol, <strong>2007</strong>. 50(5): p. 423-3<strong>1.</strong><br />

5<strong>1.</strong> Quaschning, T., <strong>et</strong> <strong>al</strong>., Lack of endotheli<strong>al</strong> nitric oxide synthase promotes<br />

endothelin-induced hypertension: lessons from endothelin-1<br />

transgenic/endotheli<strong>al</strong> nitric oxide synthase knockout mice. J Am Soc Nephrol,<br />

<strong>2007</strong>. 18(3): p. 730-40.<br />

52. Rubenwolf, P., <strong>et</strong> <strong>al</strong>., [Antiphospholipid antibody syndrome: a priori a<br />

contraindication to kidney transplantation]. Aktuelle Urol, <strong>2007</strong>. 38(2): p. 132-6.<br />

53. Sartorio, C.L., <strong>et</strong> <strong>al</strong>., Miner<strong>al</strong>ocorticoid receptor blockade improves vasomotor<br />

dysfunction <strong>and</strong> vascular oxidative stress early after myocardi<strong>al</strong> infarction.<br />

Hypertension, <strong>2007</strong>. 50(5): p. 919-25.<br />

54. Schafer, A., <strong>et</strong> <strong>al</strong>., Late thrombosis of a drug-eluting stent during combined antiplatel<strong>et</strong><br />

therapy in a clopidogrel nonresponsive diab<strong>et</strong>ic patient: sh<strong>al</strong>l we routinely<br />

test platel<strong>et</strong> function Thromb Haemost, <strong>2007</strong>. 97(5): p. 862-5.<br />

55. Schafer, A., M. Eigenth<strong>al</strong>er, <strong>and</strong> J. Bauersachs, Severe neutropenia under<br />

clopidogrel treatment three weeks after coronary stenting. Thromb Haemost,<br />

<strong>2007</strong>. 97(2): p. 317-8.<br />

56. Schafer, A., <strong>et</strong> <strong>al</strong>., Telmisartan improves vascular function <strong>and</strong> reduces platel<strong>et</strong><br />

activation in rats with streptozotocin-induced diab<strong>et</strong>es mellitus. Pharmacol Res,<br />

<strong>2007</strong>. 56(3): p. 217-23.<br />

57. Schafer, A., <strong>et</strong> <strong>al</strong>., Improved endotheli<strong>al</strong> function <strong>and</strong> reduced platel<strong>et</strong> activation<br />

by chronic HMG-CoA-reductase inhibition with rosuvastatin in rats with<br />

streptozotocin-induced diab<strong>et</strong>es mellitus. Biochem Pharmacol, <strong>2007</strong>. 73(9): p.<br />

1367-75.<br />

58. Schafer, A., <strong>et</strong> <strong>al</strong>., The CX3C chemokine fract<strong>al</strong>kine induces vascular dysfunction<br />

by generation of superoxide anions. Arterioscler Thromb Vasc Biol, <strong>2007</strong>. 27(1):<br />

p. 55-62.<br />

59. Schneider, R., <strong>et</strong> <strong>al</strong>., Downregulation of organic anion transporters OAT1 <strong>and</strong><br />

OAT3 correlates with impaired secr<strong>et</strong>ion of para-aminohippurate after ischemic<br />

acute ren<strong>al</strong> failure in rats. Am J Physiol Ren<strong>al</strong> Physiol, <strong>2007</strong>. 292(5): p. F1599-<br />

605.<br />

60. Schulz, C., <strong>et</strong> <strong>al</strong>., Chemokine fract<strong>al</strong>kine mediates leukocyte recruitment to<br />

inflammatory endotheli<strong>al</strong> cells in flowing whole blood: a critic<strong>al</strong> role for P-selectin<br />

expressed on activated platel<strong>et</strong>s. Circulation, <strong>2007</strong>. 116(7): p. 764-73.<br />

6<strong>1.</strong> Schwedler, S.B., <strong>et</strong> <strong>al</strong>., Native C-reactive protein induces endotheli<strong>al</strong> dysfunction<br />

in ApoE-/- mice: implications for iNOS <strong>and</strong> reactive oxygen species.<br />

Atherosclerosis, <strong>2007</strong>. 195(2): p. e76-84.<br />

62. Stel, V.S., <strong>et</strong> <strong>al</strong>., The r<strong>and</strong>omized clinic<strong>al</strong> tri<strong>al</strong>: an unbeatable st<strong>and</strong>ard in clinic<strong>al</strong><br />

research Kidney Int, <strong>2007</strong>. 72(5): p. 539-42.<br />

63. Stork, S., <strong>et</strong> <strong>al</strong>., Low levels of adiponectin predict worsening of arteri<strong>al</strong><br />

morphology <strong>and</strong> function. Atherosclerosis, <strong>2007</strong>. 194(2): p. e147-53.<br />

64. Strotmann, J., <strong>et</strong> <strong>al</strong>., Progression of Fabry cardiomyopathy. Clin Ther, <strong>2007</strong>. 29<br />

Suppl A: p. S13-4.<br />

65. Tatters<strong>al</strong>l, J., <strong>et</strong> <strong>al</strong>., EBPG guideline on di<strong>al</strong>ysis strategies. Nephrol Di<strong>al</strong><br />

Transplant, <strong>2007</strong>. 22 Suppl 2: p. ii5-2<strong>1.</strong><br />

66. Terzolo, M., <strong>et</strong> <strong>al</strong>., Adjuvant mitotane treatment for adrenocortic<strong>al</strong> carcinoma. N

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!